Cover Image
市場調查報告書

Tamsulosin的中國市場

Investigation Report on China Tamsulosin Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332297
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Tamsulosin的中國市場 Investigation Report on China Tamsulosin Market, 2010-2019
出版日期: 2015年06月04日 內容資訊: 英文 30 Pages
簡介

中國的前列腺治療藥市場,是非常集中化做,以Finasteride,Tamsulosin及Prostat的3種產品佔90%以上的市場佔有率。Tamsulosin,進入中國市場以來,急速拓展其佔有率,2005年為5000萬人民幣的銷售量,2014年達了2億100萬人民幣。

本報告提供中國的Tamsulosin市場規模、主要製藥公司及各劑型的市場佔有率、銷售價格、市場預測等資訊。

第1章 Tamsulosin的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國的Tamsulosin的市場簡介

  • Tamsulosin的專利及核準情況
  • 主要製藥公司
  • Tamsulosin銷售情形

第3章 中國的Tamsulosin銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國的Tamsulosin的主要製藥公司市場佔有率調查

  • 銷售額為基礎的市場佔有率
  • 銷售量為基礎的市場佔有率

第5章 中國的Tamsulosin的劑型的相關調查

  • 各劑型的市場佔有率:銷售額為基礎
  • 各劑型的市場佔有率:銷售量為基礎

第6章 中國的醫院的Tamsulosin的標準價格

  • Kunming Jida Pharmaceutical Co., Ltd (Jidabente)
  • Astellas Pharma China, Inc (Harnal)
  • 山之內製藥 (Harnal)
  • Astellas Pharma Inc. (Harnal)
  • Jiangsu Heng Rui Medicine Co., Ltd
  • Zhejiang Hailisheng Pharmaceutical Co., Ltd (Qi Suo)

第7章 中國市場中Tamsulosin的主要製藥公司

  • Zhejiang Hailisheng Pharmaceutical Co., Ltd
  • Jiangsu Heng Rui Medicine Co., Ltd
  • Kunming Jida Pharmaceutical Co., Ltd
  • 山之內製藥
  • Astellas Pharma Inc.

第8章 中國的Tamsulosin的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506188

Benign Prostate Hyperplasis (BPH) is prevalent among elderly men, influencing one third of those aged above 50. BPH is a benign histopathological disease characterized by hyperplasia of stromal and epithelial cells which results in enlarged prostate and then compressed urethra that makes urination difficult. BPH is treatable with medication and operation. Two main categories of drugs are α1-adrenergic receptor blocker and 5α-reductase inhibitor. The former one can effectively palliate symptoms through relaxing bladder neck and prostate and reducing urethral pressure, but it can't cure BPH.

Compared with other α1-adrenergic receptor blockers, tamsulosin hydrochloride developed by Yamanouchi enjoys higher selectivity and lower risk of urinary tract infections and therefore is fitter for BPH treatment. Ever since its debut in 1993 in Japan, tamsulosin hydrochloride has been sold in various brands in 64 countries according to Yamanouchi's authorization to Boehringer Ingelheim.

Prostate drug market is highly concentrated in China. Three kinds of prostate drugs - finasteride, tamsulosin and prostat which occupy over 90% of prostate drug market altogether, reported over 10 million sales in sample hospitals in 2005. Tamsulosin develops rapidly after entering China with annual sales less than CNY 50 million in 2005 rising to CNY 201 million in 2014 and CAGR reaching 16.98% during this period. Tamsulosin enjoys a vast market demand in China and products made by Zhejiang Hailisheng Pharmaceutical Co., Ltd, Jiangsu Heng Rui Medicine Co., Ltd, Astellas Pharma Inc, Yamanouchi Pharmaceutical Co., Ltd and Kunming Jida Pharmaceutical Co., Ltd have taken up a large share of the market.

With the aging of the population in China, the incidence of BPH and its number of cases will keep going up. The market size of tamsulosin in China is expected to keep expanding in the next few years.

Readers can get at least the following information through this report:

  • market size of tamsulosin in China
  • major manufacturers of tamsulosin in Chinese market and their market share
  • retail price of tamsulosin in Chinese market
  • market outlook of tamsulosin in China

The author suggests the following groups of people purchase this report:

  • manufacturers of prostate drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Tamsulosin

  • 1.1. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Tamsulosin in China

  • 2.1. Patent and Approval Status of Tamsulosin in China
  • 2.2. Major Manufacturers
  • 2.3. Sales Status of Tamsulosin in China

3. Survey on Sales Status of Tamsulosin in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Tamsulosin in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Tamsulosin in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Tamsulosin in Chinese Hospitals in 2014

  • 6.1. Kunming Jida Pharmaceutical Co., Ltd (Trade Name: Jidabente)
  • 6.2. Astellas Pharma China, Inc (Trade Name: Harnal)
  • 6.3. Yamanouchi Pharmaceutical Co., Ltd (Trade Name: Harnal)
  • 6.4. Astellas Pharma Inc (Trade Name: Harnal)
  • 6.5. Jiangsu Heng Rui Medicine Co., Ltd
  • 6.6. Zhejiang Hailisheng Pharmaceutical Co., Ltd (Trade Name: Qi Suo)

7. Major Manufacturers of Tamsulosin in Chinese Market, 2010-2014

  • 7.1. Zhejiang Hailisheng Pharmaceutical Co., Ltd
  • 7.2. Jiangsu Heng Rui Medicine Co., Ltd
  • 7.3. Kunming Jida Pharmaceutical Co., Ltd
  • 7.4. Yamanouchi Pharmaceutical Co., Ltd
  • 7.5. Astellas Pharma Inc

8. Market Outlook of Tamsulosin in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Tamsulosin in China
  • Chart Approval Status of Tamsulosin in China
  • Chart Sales Status of Tamsulosin in China, 2010-2014
  • Chart Sales Value of Tamsulosin in China, 2010-2014
  • Chart Sales Value of Tamsulosin in Some Regions in China, 2010-2014
  • Chart Sales Volume of Tamsulosin in China, 2010-2014
  • Chart Sales Volume of Tamsulosin in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Tamsulosin for Sales Value, 2010-2014
  • Chart Sales Value and Market Share of Tamsulosin Made by Astellas, 2010-2014
  • Chart Sales Value and Market Share of Tamsulosin Made by Kunming Jida, 2010-2014
  • Chart Sales Value and Market Share of Tamsulosin Made by Zhejiang Hailisheng, 2010-2014
  • Chart Sales Value and Market Share of Tamsulosin Made by Yamanouchi, 2010-2014
  • Chart Sales Value and Market Share of Tamsulosin Tablets in China, 2010-2014
  • Chart Price of Tamsulosin Made by Kunming Jida Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tamsulosin Made by Astellas Pharma China, Inc in Some Chinese Cities in 2014
  • Chart Price of Tamsulosin Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Chinese Cities in 2014
  • Chart Price of Tamsulosin Made by Astellas Pharma Inc (JA) in Some Chinese Cities in 2014
  • Chart Price of Tamsulosin Made by Jiangsu Heng Rui Medicine Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Tamsulosin Made by Zhejiang Hailisheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top